CID 12087505

1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea

Structural Information

Molecular Formula
C19H20N6O3S2
SMILES
C1CN(CCN1C2=CC=CC=N2)S(=O)(=O)C3=CC=CC(=C3)NC(=O)NC4=NC=CS4
InChI
InChI=1S/C19H20N6O3S2/c26-18(23-19-21-8-13-29-19)22-15-4-3-5-16(14-15)30(27,28)25-11-9-24(10-12-25)17-6-1-2-7-20-17/h1-8,13-14H,9-12H2,(H2,21,22,23,26)
InChIKey
NJPVZSIGDRLLTD-UHFFFAOYSA-N
Compound name
1-[3-(4-pyridin-2-ylpiperazin-1-yl)sulfonylphenyl]-3-(1,3-thiazol-2-yl)urea
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

4
Patents

444.10382 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 445.11110 196.8
[M+Na]+ 467.09304 202.4
[M-H]- 443.09654 203.6
[M+NH4]+ 462.13764 201.7
[M+K]+ 483.06698 195.2
[M+H-H2O]+ 427.10108 187.3
[M+HCOO]- 489.10202 204.5
[M+CH3COO]- 503.11767 203.5
[M+Na-2H]- 465.07849 199.2
[M]+ 444.10327 194.8
[M]- 444.10437 194.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe